Point72 Hong Kong LTD 9 Meters Biopharma, Inc. Transaction History

Point72 Hong Kong LTD

  • $1.57 Billion
  • Q2 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 15, 2022
SELL
$0.26 - $0.64 $3,978 - $9,793
-15,303 Closed
0 $0
Q1 2022

May 16, 2022
BUY
$0.52 - $1.0 $7,957 - $15,303
15,303 New
15,303 $9,000
Q3 2021

Nov 15, 2021
SELL
$1.03 - $1.41 $13,197 - $18,066
-12,813 Closed
0 $0
Q2 2021

Aug 16, 2021
BUY
$1.04 - $1.5 $13,325 - $19,219
12,813 New
12,813 $14,000

Others Institutions Holding NMTR

# of Institutions
3
Shares Held
67.9K
Call Options Held
0
Put Options Held
0
View Full List

About 9 METERS BIOPHARMA, INC.

NMTR Quotes by TradingView
  • Ticker NMTR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 12,955,400
  • Market Cap $259K
  • Description
  • 9 Meters Biopharma, Inc., a clinical-stage biopharmaceutical company, focuses on treatments for people with rare digestive diseases, gastrointestinal conditions with unmet needs, and debilitating disorders. The company is developing Larazotide, an 8-amino acid peptide, which is in Phase 3 clinical trial for the treatment of celiac disease, as we...
More about NMTR
Track This Portfolio

Track Point72 Hong Kong LTD Portfolio

Follow Point72 Hong Kong LTD and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Point72 Hong Kong LTD, based on Form 13F filings with the SEC.

News

Stay updated on Point72 Hong Kong LTD with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email